This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
S. Guzzetti et al., “Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation,” Circulation, vol. 112, no. 4, pp. 465–470, Jul. 2005, doi: 10.1161/CIRCULATIONAHA.104.518449.Open DOISearch in Google Scholar
H. V Huikuri, T. Mäkikallio, K. E. Juhani Airaksinen, R. Mitrani, A. Castellanos, and R. J. Myerburg, “Measurement of Heart Rate Variability: A Clinical Tool or a Research Toy?,” J. Am. Coll. Cardiol., vol. 34, pp. 1878–1883, 1999, doi: 10.1016/S0735-1097(99)00468-4.Open DOISearch in Google Scholar
J. Achten and A. E. Jeukendrup, “Heart rate monitoring: applications and limitations,” Sports Med., vol. 33, no. 7, pp. 517–538, 2003, doi: 10.2165/00007256-200333070-00004.Open DOISearch in Google Scholar
M. Sadaka, A. Aboelela, S. Arab, and M. Nawar, “Electrocardiogram as prognostic and diagnostic parameter in follow up of patients with heart failure,” Alexandria J. Med., vol. 49, no. 2, pp. 145–152, Jun. 2013, doi: 10.1016/J.AJME.2012.09.002.Open DOISearch in Google Scholar
D. Moher et al., “Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement,” PLoS Medicine, vol. 6, no. 7. Jul. 2009. doi: 10.1371/journal.pmed.1000097.Open DOISearch in Google Scholar
B. M. Szabó, D. J. van Veldhuisen, J. Brouwer, J. Haaksma, and K. I. Lie, “Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease,” Am. J. Cardiol., vol. 76, no. 10, pp. 713–716, Oct. 1995, doi: 10.1016/S0002-9149(99)80204-5.Open DOISearch in Google Scholar
S. Guzzetti et al., “Linear and nonlinear 24 h heart rate variability in chronic heart failure,” Auton. Neurosci., vol. 86, no. 1–2, pp. 114–119, Dec. 2000, doi: 10.1016/S1566-0702(00)00239-3.Open DOISearch in Google Scholar
V. N. Patel, B. R. Pierce, R. K. Bodapati, D. L. Brown, D. G. Ives, and P. K. Stein, “Association of Holter-Derived Heart Rate Variability Parameters With the Development of Congestive Heart Failure in the Cardiovascular Health Study,” JACC. Heart Fail., vol. 5, no. 6, pp. 423–431, Jun. 2017, doi: 10.1016/J.JCHF.2016.12.015.Open DOISearch in Google Scholar
M. Galinier et al., “Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure,” Eur. Heart J., vol. 21, no. 6, pp. 475–482, Mar. 2000, doi: 10.1053/EUHJ.1999.1875.Open DOISearch in Google Scholar
S. Guzzetti et al., “Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure,” Eur. Heart J., vol. 26, no. 4, pp. 357–362, Feb. 2005, doi: 10.1093/EURHEARTJ/EHI067.Open DOISearch in Google Scholar
P. Ponikowski et al., “Heart rhythms, ventricular arrhythmias, and death in chronic heart failure,” J. Card. Fail., vol. 2, no. 3, pp. 177–183, 1996, doi: 10.1016/S1071-9164(96)80039-X.Open DOISearch in Google Scholar
C. F. Notarius, J. Spaak, B. L. Morris, and J. S. Floras, “Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure,” J. Card. Fail., vol. 13, no. 6, pp. 470–475, Aug. 2007, doi: 10.1016/J.CARDFAIL.2007.03.014.Open DOISearch in Google Scholar
A. Voss et al., “Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification,” Front. Physiol., vol. 4, 2013, doi: 10.3389/FPHYS.2013.00364.Open DOISearch in Google Scholar
J. Sztajzel, “Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system,” Swiss Med. Wkly., vol. 134, no. 35–36, pp. 514–522, Sep. 2004, doi: 10.4414/SMW.2004.10321.Open DOISearch in Google Scholar
N. Chattipakorn, T. Incharoen, N. Kanlop, and S. Chattipakorn, “Heart rate variability in myocardial infarction and heart failure,” Int. J. Cardiol., vol. 120, no. 3, pp. 289–296, Sep. 2007, doi: 10.1016/J.IJCARD.2006.11.221.Open DOISearch in Google Scholar
H. V. Huikuri and P. K. Stein, “Heart rate variability in risk stratification of cardiac patients,” Prog. Cardiovasc. Dis., vol. 56, no. 2, pp. 153–159, Sep. 2013, doi: 10.1016/J.PCAD.2013.07.003.Open DOISearch in Google Scholar
J. J. Atherton et al., “Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status,” Heart Vessels, vol. 13, no. 6, pp. 269–277, 1998, doi: 10.1007/BF03257231.Open DOISearch in Google Scholar
H. A. Malave, A. A. Taylor, J. Nattama, A. Deswal, and D. L. Mann, “Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure,” Chest, vol. 123, no. 3, pp. 716–724, Mar. 2003, doi: 10.1378/CHEST.123.3.716.Open DOISearch in Google Scholar
M. J. Pearson and N. A. Smart, “Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis,” Heart Fail. Rev., vol. 23, no. 1, pp. 91–108, Jan. 2018, doi: 10.1007/S10741-017-9662-Z.Open DOISearch in Google Scholar
F. Besnier et al., “Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial,” Ann. Phys. Rehabil. Med., vol. 62, no. 5, pp. 321–328, Sep. 2019, doi: 10.1016/J.REHAB.2019.06.013.Open DOISearch in Google Scholar
J. Brouwer et al., “Heart rate variability in patients with mild to moderate heart failure: Effects of neurohormonal modulation by digoxin and ibopamine,” J. Am. Coll. Cardiol., vol. 26, no. 4, pp. 983–990, 1995, doi: 10.1016/0735-1097(95)00285-3.Open DOISearch in Google Scholar
L. Guedon-Moreau et al., “Effect of ramipril on heart rate variability in digitalis-treated patients with chronic heart failure,” Cardiovasc. Drugs Ther., vol. 11, no. 4, pp. 531–536, 1997, doi: 10.1023/A:1007763131888/METRICS.Open DOISearch in Google Scholar
F. Pousset et al., “Effects of Bisoprolol on heart rate variability in heart failure,” Am. J. Cardiol., vol. 77, no. 8, pp. 612–617, Mar. 1996, doi: 10.1016/S0002-9149(97)89316-2.Open DOISearch in Google Scholar
A. Bozkurt, A. Birand, and G. Z. Kudaiberdieva, “Effects of perindopril on autonomic modulation of the heart and left ventricular function: An open-label study,” Curr. Ther. Res., vol. 63, no. 1, pp. 43–51, Jan. 2002, doi: 10.1016/S0011-393X(02)80006-6.Open DOISearch in Google Scholar
H. Tomiyama et al., “Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure,” Am. Heart J., vol. 137, no. 3, pp. 543–548, Mar. 1999, doi: 10.1016/S0002-8703(99)70504-1.Open DOISearch in Google Scholar
D. Aronson and A. J. Burger, “Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure,” Ann. Noninvasive Electrocardiol., vol. 6, no. 2, pp. 98–106, 2001, doi: 10.1111/J.1542-474X.2001.TB00093.X.Open DOISearch in Google Scholar
M. E. Korkmaz, H. Müderrisoglu, M. Uluçam, and B. Özin, “Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure,” Am. J. Cardiol., vol. 86, no. 6, pp. 649–653, Sep. 2000, doi: 10.1016/S0002-9149(00)01046-8.Open DOISearch in Google Scholar
K. M. Yee, S. D. Pringle, and A. D. Struthers, “Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure,” J. Am. Coll. Cardiol., vol. 37, no. 7, pp. 1800–1807, Jun. 2001, doi: 10.1016/S0735-1097(01)01243-8.Open DOISearch in Google Scholar
J. I. Davies, M. D. Witham, and A. D. Struthers, “Autonomic effects of spironolactone and MR blockers in heart failure,” Heart Fail. Rev., vol. 10, no. 1, pp. 63–69, Jan. 2005, doi: 10.1007/S10741-005-2350-4.Open DOISearch in Google Scholar
A. Hamaad, M. Sosin, G. Y. H. Lip, and R. J. MacFadyen, “Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure,” Cardiovasc. drugs Ther., vol. 19, no. 3, pp. 183–187, May 2005, doi: 10.1007/S10557-005-2219-8.Open DOISearch in Google Scholar
V. Spallone and P. Valensi, “SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement,” Diabetes Metab., vol. 47, no. 4, p. 101224, Jul. 2021, doi: 10.1016/J.DIABET.2021.101224.Open DOISearch in Google Scholar
A. J. Burger and D. Aronson, “Effect of Diabetes Mellitus on Heart Rate Variability in Patients with Congestive Heart Failure,” Pacing Clin. Electrophysiol., vol. 24, no. 1, pp. 53–59, Jan. 2001, doi: 10.1046/J.1460-9592.2001.00053.X.Open DOISearch in Google Scholar
A. Mortara and L. Tavazzi, “Prognostic implications of autonomic nervous system analysis in chronic heart failure: Role of heart rate variability and baroreflex sensitivity,” Arch. Gerontol. Geriatr., vol. 23, no. 3, pp. 265–275, Nov. 1996, doi: 10.1016/S0167-4943(96)00727-3.Open DOISearch in Google Scholar
G. Myers, M. Workman, C. Birkett, D. Ferguson, and M. Kienzle, “Problems in measuring heart rate variability of patients with congestive heart failure,” J. Electrocardiol., vol. 25 Suppl, no. SUPPL., pp. 214–219, 1992, doi: 10.1016/0022-0736(92)90105-9.Open DOISearch in Google Scholar
G. Q. Wu et al., “Chaotic signatures of heart rate variability and its power spectrum in health, aging and heart failure,” PLoS One, vol. 4, no. 2, Feb. 2009, doi: 10.1371/JOURNAL.PONE.0004323.Open DOISearch in Google Scholar
